Easton Capital joins £9M Cumulus Oncology investment round
Month: January 2024
Easton Capital has completed an investment in Cumulus Oncology alongside the Scottish National Investment Bank and a consortium of private investors led by Eos Advisory. The £9M equity investment will support Cumulus’s portfolio of companies dedicated to developing cancer treatments and fast-tracking the development of new drugs from discovery through clinical trials to patient application.
Founded in 2017 by CEO Dr Clare Wareing, Cumulus Oncology is a cancer therapeutics development company. Based in Edinburgh, it is Europe’s first biotech creation studio and drug discovery accelerator specialising in oncology. Cumulus takes a fresh approach to drug development as both the parent and creator of multiple spin-out companies.
Easton Capital provides long term capital investment to support high growth businesses. It is a division of the Easton Group – a family-owned property and investment business with 50 years’ experience of investing in our communities.
“We are very pleased to announce our investment in Cumulus Oncology, and proud to support its development of pioneering cancer treatments.
Cumulus has a unique business model that allows for the scientific validation of oncology therapies to be fast-tracked while de-risking the investment across a portfolio of assets.”
Steven Easton
Director at Easton Group
Easton Group News
Easton Capital backs £8M Naturbeads investment
Easton Capital has completed an investment in Naturbeads alongside a consortium of private investors led by Eos Advisory. The £8M Series A round will…
LDC Top 50 Most Ambitious Business Leaders
Peter and Steven Easton, Co-founders of Green Home Systems, have been recognised as one of The LDC Top 50 Most Ambitious Business Leaders for 2024,…
The Herald Business HQ feature
Easton Group directors, Peter and Steven Easton, talk to The Herald Business HQ about fifty years of family business.
